Johnson & Johnson will invest $1 billion to build a cell therapy factory in Pennsylvania.

Johnson & Johnson will invest over $1 billion to build a new generation cell therapy production facility in Montgomery County, Pennsylvania. The company stated that the facility will create over 4,000 construction jobs and 500 biomanufacturing jobs. This facility is part of the company's plan to invest $55 billion in manufacturing, R&D, and technology in the United States by early 2029. Some pharmaceutical companies have announced plans to invest in building new drug production facilities in the United States, usually in exchange for tariff exemptions on imported drugs imposed by President Trump.